HistologiX offers a range of validated and optimised IHC immuno-oncology biomarker assays with quantitative image analysis tools to deliver valuable immunological insight into tumour immune processes.
Our robust approach to the identification, quantification, localisation, and spatial relationships of immune biomarkers in tumour tissues supports clients in making informed decisions for advancing their immunotherapeutic strategy to market. Our experts also have the ability to interpret data from these assays.
Our understanding of the complexity of the tumour immune microenvironment in tissues from preclinical mouse models through to patients on clinical trial provides valuable information for the drug discovery process.
Download your copy of our brochure to learn more about how we can help support your immuno-oncology research.